Skip to content

Depression: all studies

Page 334 of 1,036: studies 3,331 to 3,340 of 10,358, newest first. Back to the depression overview

Research

Changes in Depressive Symptoms Following Mindfulness Training in Female Patients With Abdominal or Abdominopelvic Cancer: A Preliminary Non-Randomized Controlled Study.

Psycho-Oncology August 1, 2026 Hui Kou, Qiye Li, Xiaomei Hu et al.

Objectives: To examine whether a brief mindfulness training program was associated with changes in depressive symptoms among female patients with cancer, to explore potential psychological processes related to symptom change, and to examine differences in pre-to post-training changes according to baseline psychological risk profiles. Methods: This exploratory non-randomized controlled study...

DOI: 10.1002/pon.70585 (opens in new tab) Full text (opens in new tab) Depression Humans Colorectal neoplasms Ovarian neoplasms +12

Low Dose Ketamine Preconditions Astrocyte Mitochondria to Achieve Antidepressant Efficacy via Adenosine, Humanin, and Melatonin Upregulation and Efflux.

Alpha psychiatry August 2026 George Anderson

Understanding the physiological changes induced by ketamine in mood disorders, while reducing its side effects, is likely to contribute to a more comprehensive understanding of the physiology underlying mood disorders, as well as to the development of faster-acting and more efficacious antidepressant treatments. An extensive review of the literature on ketamine and the pathophysiology of...

Role of concomitant benzodiazepines, lithium, and lamotrigine in modulating the antidepressant effects of subcutaneous esketamine in patients with treatment-resistant depressive episodes: A retrospective naturalistic study.

Journal of Affective Disorders August 1, 2026 João Paulo Atidio, Rodrigo Simonini Delfino, Igor Saque Garios et al.

Ketamine and esketamine have been increasingly used as adjunctive treatments for treatment-resistant depression (TRD), yet evidence on pharmacological interactions with commonly prescribed psychotropic medications remains limited. This study evaluated the association between concomitant lamotrigine, lithium, and benzodiazepine use and antidepressant outcomes during subcutaneous esketamine...

The functional role of ERK activity in esketamine's antidepressant effects.

Pharmacology, Biochemistry, and Behavior July 26, 2026 Peng Zhang, Mengyu Wu, Keke Zhang et al.

Esketamine has been approved for the treatment of treatment-resistant depression. However, there is an unmet clinical need to extend the duration of esketamine's action to reduce the high recurrence rate after drug withdrawal and the potential side effects of repeated esketamine use. Here, we found that increasing extracellular signal-regulated kinase (ERK) activity by pharmacologically...

Bidirectional control of vesicular GABA release, LTP, and amotivation by GluN2D-selective allosteric modulators and ketamine.

Cell Reports July 24, 2026 Viktor J Oláh, Isabelle F Witteveen, Tue G Banke et al.

GABAergic inhibitory interneurons balance brain activity by suppressing excessive excitatory signaling and shaping network oscillations. Despite this critical function, our understanding of how neural circuits regulate GABAergic systems remains limited. Although N-methyl-D-aspartate receptor (NMDAR) functionality is defined by the GluN2A-D subunits, the interneuron NMDAR subunit composition...

Comparative effectiveness of face-to-face and digital mindfulness-based interventions on maternal mental health resilience to psychological distress: a systematic review and meta-analysis.

Psychology, Health & Medicine July 19, 2026 Sheetal Rohit Sharma, Seeta Devi, Srikanth Pallerla et al.

Maternal mental health is a major global concern affecting both pregnant women and fetal development. Mindfulness-based interventions (MBIs) have shown benefits in improving maternal mental health. This study assessed the effects of digital and conventional face-to-face MBIs on psychological distress among pregnant women. Two independent reviewers conducted the literature search and study...

DOI: 10.1080/13548506.2026.2691409 (opens in new tab) Depression Anxiety Psychological distress Mindfulness-based interventions +2

The Efficacy of Hypnotherapy in Reducing Burnout and Related Psychopathologies: Protocol for a Systematic Review and Meta-Analysis.

JMIR Research Protocols July 17, 2026 Santosha Veeramachaneni, Elizabeth Park, Jeffrey Martin et al.

Hypnosis is a focused state of consciousness that enhances concentration, attention, and responsiveness to suggestion. It has shown efficacy in treating psychiatric disorders such as depression, anxiety, and posttraumatic stress disorder (PTSD). However, its potential for addressing burnout and related symptoms remains underexplored. This systematic review and meta-analysis aims to assess the...

An Online Mindfulness-Based Intervention for Tic Disorders: Effect on Comorbid Symptoms.

Movement Disorders Clinical Practice July 16, 2026 Kiran Kaur, W Alan Brown, Susanne Hoeppner et al.

Mindfulness-based approaches show promise for reducing tic severity, yet little is known about their effect on comorbid symptoms. The objective was to evaluate secondary outcomes from a pilot randomized controlled trial comparing mindfulness-based intervention for tics (MBIT) with psychoeducation, relaxation, and supportive therapy (PRST). Twenty-eight adults with Tourette's syndrome or...

A Self-Guided Mobile Mindfulness Intervention Embedded in Daily Routines for Adults With Mild to Moderate Psychological Distress: Randomized Controlled Trial.

JMIR Mental Health July 15, 2026 Xichun Wu, Jackelyn De Alwis, Zenan Dou et al.

Background: Mobile mindfulness interventions have shown promise for reducing anxiety and depressive symptoms, but sustaining engagement remains a persistent challenge. Many digital programs still rely on formal practice that requires dedicated time, which may be difficult to integrate into daily life. Objective: This randomized controlled trial evaluated Habitual Mindfulness Practice (HMP), a...

The potential role of psychedelics in palliative care

Medycyna Paliatywna July 15, 2026 Maciej Sulerzycki, Katarzyna Pomykała, Katarzyna Giemza et al.

In recent years, there has been a growing interest in the therapeutic use of psychedelics. In palliative medicine, they are being considered as an alternative approach to treating depression, existential distress, and chronic pain conditions. This review presents current literature on the use of psychedelic substances such as psilocybin, lysergic acid diethylamide,...